The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Blinding in randomised trials: hiding who got what
Abstract
Blinding embodies a rich history spanning over two centuries. Most researchers worldwide understand blinding terminology, but confusion lurks beyond a general comprehension. Terms such as single blind, double blind, and triple blind mean different things to different people. Moreover, many medical researchers confuse blinding with allocation concealment. Such confusion indicates misunderstandings of both. The term blinding refers to keeping trial participants, investigators (usually health-care providers), or assessors (those collecting outcome data) unaware of the assigned intervention, so that they will not be influenced by that knowledge. Blinding usually reduces differential assessment of outcomes (information bias), but can also improve compliance and retention of trial participants while reducing biased supplemental care or treatment (sometimes called co-intervention). Many investigators and readers naïvely consider a randomised trial as high quality simply because it is double blind, as if double-blinding is the sine qua non of a randomised controlled trial. Although double blinding (blinding investigators, participants, and outcome assessors) indicates a strong design, trials that are not double blinded should not automatically be deemed inferior. Rather than solely relying on terminology like double blinding, researchers should explicitly state who was blinded, and how. We recommend placing greater credence in results when investigators at least blind outcome assessm…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An independent researcher conducted mixed randomisation using both simple and blocked methods with 1:1 allocation to minimise selection bias [20].”
From Comparing face-to-face and online LSVT®LOUD speech training using LSVT®Coach in patients with Parkinson’s disease: a pilot randomised controlled trial (2025) · cites this paper as [20]
In the citing paper
“Given the intervention’s interactive nature, it was impossible to blind the participants to their group assignments [32].”
From Smartphone-Based Speech Therapy for Poststroke Dysarthria: Pilot Randomized Controlled Trial Evaluating Efficacy and Feasibility (2024) · cites this paper as [32]
In the citing paper
“the use of blinding for research personnel, such as data collectors, data analysts, or the principal investigator, and members of the medical care team, such as physicians, psychologists, or nurses, with regards to group allocation is essential to mitigate threats to construct validity.”
From Best Practice Recommendations for Conducting and Reporting Controlled Trials in Clinical Hypnosis Research (2024) · cites this paper as [100]
In the citing paper
“The benefits include (but are not limited to) lower likelihood to transfer expectations and attitudes about intervention effectiveness to participants and to bias results through differentially adjusting dose, withdrawing participants, or encouraging or discouraging participants to continue in the trial, and so on. 100”
From Best Practice Recommendations for Conducting and Reporting Controlled Trials in Clinical Hypnosis Research (2024) · cites this paper as [100]
In the citing paper
“Blinding of participants can hold additional benefits as well, such as decreased likelihood for dropout or seeking additional adjunctive interventions. 100”
From Best Practice Recommendations for Conducting and Reporting Controlled Trials in Clinical Hypnosis Research (2024) · cites this paper as [100]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Self-citationMoher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Self-citationThe Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
Self-citationMoher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. J. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,930
Practical statistics for medical research
King, M. (1992) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(92)90046-5 · Cited by 1,659
Clinical trials: A practical approach
Daly, M. J. (1984) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(84)90515-7 · Cited by 1,053
Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial
(2000) · The Lancet · doi:10.1016/s0140-6736(00)03495-4 · Cited by 997
A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke
The Canadian Cooperative Study Group (1978) · New England Journal of Medicine · doi:10.1056/nejm197807132990201 · Cited by 957
Research works printed but not linked: 2
- 1998, International conference on harmonisation: guidance on statistical principles for clinical trials, Fed Regist, 63, 49583
- Sackett, 1986, Tests for the blindness of randomized trials may not, Clin Res, 34, 711A
Cited by
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Self-citationCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · BMJ · doi:10.1136/bmj.c332 · Cited by 9,329
Self-citationCONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00232 · Cited by 3,824
Self-citationCONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000251 · Cited by 2,296
Self-citationCONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., & Moher, D. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72352 · Cited by 2,165
“We also eliminated text on ‘‘how the success of blinding (masking) was assessed’’ because of a lack of empirical evidence supporting the practice as well as theoretical concerns about the validity of any such assessment [23,24] Item 12a (statistical methods)dWe added that statistical methods should also be provided fo…”
Self-citation
Metadata
- Authors
- Schulz, K. F., & Grimes, D. A.
- Affiliations
- Family Health International 360 (US)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 359
- Issue
- 9307
- Pages
- 696-700
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2002251042
- Cited by
- 952
- References
- 36
- Citations by year
- 2026: 46 · 2025: 61 · 2024: 60 · 2023: 49 · 2022: 36 · 2021: 58 · 2020: 48 · 2019: 29 · 2018: 49 · 2017: 41 · 2016: 61 · 2015: 53 · 2014: 59 · 2013: 47 · 2012: 30
- FWCI
- 23.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Keywords
- blinding, randomized controlled trials, allocation concealment, double blinding, information bias, outcome assessment bias, trial reporting quality
- MeSH terms
- Double-Blind Method, Humans, Placebos, Epidemiologic Research Design, Randomized Controlled Trials as Topic, Single-Blind Method
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blinding in randomised trials: hiding who got what. https://app.cochat.ai/papers/10.1016/s0140-6736(02)07816-9
- The paper
- Schulz, K. F., & Grimes, D. A. (2002). Blinding in randomised trials: hiding who got what. The Lancet. https://doi.org/10.1016/s0140-6736(02)07816-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.